We’re almost there, & your support can make all the difference!
If you’re from a developing country, join our survey study on adherence to
@ASCO
guidelines 4 integrating
#PallCare
into standard practice
Your insights matter!
@PallOncCoP
📣Just out!! Thrilled to share our recent publication. Thank you
@montypal
🔸Shining a light on the psychological burden of cancer‼️
#PsyOnc
Thank you
@NatureMedicine
‼️
▶️
It is incredible to be
@ASCO
Featured Voice
#ASCO19
#ASCOiSpy
‼️1st psychologist to make list‼️
🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉🎉
Yay!! Thank you
@ASCO
Unbelievable opportunity!!
Terrific huge honor!!
🗳️Voting now open in the
@ASCO
elections!
A fantastic ballot including my mentor & friend
@montypal
He is running 4 Nominating Cmte
No one's done more to foster a diverse oncology workforce
A tireless advocate for pts & nextgen of oncologists
Vote here:
Exciting news! 📢 Our paper was just published at
#CGC
🎯 Increasing accurate expectations of cure over time
💡 Realistic expectations = lower anxiety symptoms
⚠️ Inaccurate expectations = severe side effects
Grateful to my mentor
@montypal
& colleagues
Exciting news‼️
Our study on FKSI-19 was published in
@OncJournal
⚠️Patients rated fatigue, lack of energy & worry as most relevant, while blood in urine, fevers & appetite were least relevant
Thanks
@tompowles1
@montypal
& committee &
@KidneyCancer
If you're interested in mindfulness, be sure to stop by our poster
@ASCO
#GU23
Poster Board G11
This smartphone-based mindfulness intervention could improve HRQOL, decrease symptoms of anxiety, FCR & fatigue
Study supported by
@kureit
Mentored by
@montypal
@Linda_E_Carlson
🎉 Just received an email from
@ASCO
Communication featuring the article I wrote for
@CancerDotNet
Grateful for the opportunity to contribute to such an esteemed platform
Check out the article for insights on
Announcing the 2021-2023
@IPOSPsychoOncol
Board of Director Election Results!
Thanks to all the nominees. Thanks also to all the IPOS eligible voting members. We had a record-breaking voter response.
Find out who has been elected here:
Thrilled to announce that I have been re-elected as a Director of
@IPOSPsychoOncol
, representing Latin and Central America
Grateful for the opportunity to continue serving this society and advocating for the needs of our region. Excited for the impactful work ahead 🤩
2023-2025
@IPOSPsychoOncol
Board of Director Election Results
Thanks to all the nominees for the 2023-2025 IPOS Board of Directors. Thanks also to all the IPOS eligible voting members.
View the results by going to
Honored to be the
@ASCO
Featured Voice
#ASCOQLTY23
‼️
Grateful for the opportunity to share insights and engage with the stellar community
Let's continue our journey towards better cancer care together
Announcing the
#ASCOQLTY23
Featured Voices! Follow along for a range of expert insights & join the discussion using the official hashtag:
#ASCOQLTY23
. ⬇️
Calling all
@ASCO
attendees!
When was your first abstract submission to the ASCO Annual Meeting?
🔅Mine: 2012, accepted for online presentation
🔆With
@montypal
's guidance, 2018 marked my first poster
🔆Excited for my inaugural oral presentation in 2024!
#ASCO24
🌟 Your support matters!
On
#GivingTuesday
(Nov 28), help us conquer cancer‼️
As a grateful recipient of 4 Merit Awards and 1 GOYIA from
@ASCO
@ConquerCancerFd
, I've personally experienced the tremendous impact.
Let's make a huge impact together!
Celebrating 16+ years of my journey in studying distress! 📚🤓 It all began when the remarkable
#JamesZabora
shared his studies with me. Two years later, I had the privilege of shadowing
#JimmieHolland
Grateful for the learnings and progress over the years
The evolving treatment landscape 4 RCC calls 4 a comprehensive approach to clinical decision-making
Recent studies on efficacy, HRQOL, & cost-effectiveness provide valuable insights 4 guiding discussions
Read more in our editorial
@EurUrolOncol
#Bonastre
Proud to share our Editorial
@JCOOP_ASCO
@montypal
#SandyLiu
“End-of-life care among patients w mRCC: Importance of a patient-centric focus in clinical decision making”
Link to our editorial:
Accompanying paper:
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 5
🇺🇸🇧🇪🇪🇺🇦🇷🇧🇷
A month ago, OncoDaily began its series on ‘100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2023.’ As committed,…
Excited to present our poster at
#ASCO23
@ASCO
!
Visit Poster Board 32 to learn about our study on the perceived relevance of questions in FKSI-19, EORTC QLQ-C30, & EQ-5D
Interesting findings reveal that only a few items were deemed relevant by our pts w RCC
@tompowles1
@montypal
Look who I had the pleasure of meeting in Sao Paulo! It was wonderful to finally meet you in person,
@AaronGoodman33
😊👋
@chadinabhan
, you've got to hear all about it!
Thank you
@ASCO
for this incredible honor!
I’m thrilled to be tweeting the
#GU20
!! It will be a fantastic meeting!
Thank you to
@montypal
I am lucky to have your full support
#BestMentorEver
📲 Announcing the
#ASCO22
Featured Voices! Follow on Twitter and/or Instagram for a range of expert insights and join the conversation using the official hashtag,
#ASCO22
👉
Thank you
@ASCO
@davisa20
the Family Friendly Service was wonderful! It made our
#ASCO19
journey easier and feasible!!
@PauloBergerot
and I are glad that our little one could stay with us all the time! Many thanks
Just published in Cancer Invest! Our study delves into anx, dep, & coping strategies among younger & older patients w cancer
@PauloBergerot
@Matthewloscalz1
@montypal
@WilliamDale_MD
‼️Exciting findings about emotion-focused coping in older patients!
I could never imagine such accomplishments
These results are reflexes of your brilliant mentorship
Thank you
@montypal
#BestMentorEver
Thank you
@ConquerCancerFd
@ASCO
4 the Merit Award! Very honored to receive this award & motivated to find other ways to improve care 4 our pts!
Fantastic study lead by
@NazliDizman
@ASCO
#GU23
- Results demonstrated a numerical increase in ORR, TTF and OS w early time of infusion, with the TTF difference reaching significance after adjustment for potential confounders
@montypal
@neerajaiims
‼️The
@NCCN
has updated the
#DistressThermometer
, a landmark tool for measuring the biopsychosocial impact of cancer and its treatment
Great way to open up a conversation w our pt, & to provide evidence-based recommendations for managing unmet needs
Hooray!
@ASCO
featured voice!!
Very excited to be at
#ASCOQLTY19
along with this wonderful team!
Let’s disseminate latest strategies & methods for quantification of patient experience, provider efficiency, quality and safety in the cancer care field
Thank you
@montypal
Honored to be part of this terrific effort
#GlobalPsyOnc
@IPOSPsychoOncol
⚜️International collab 4 assessing unmet needs of cancer survivors & family caregivers: 🔎 of HCP
👩⚕️1472 HCP
🗺️36 countries
Less than 2/3 had services to address these needs
👩💻
Thrilled to share our editorial at Cancer Investigation: Social Support as a Protective Factor for Patients with Cancer during the Pandemic 🤩
@ejphilip
#RoseCostasMuniz
@FIPOLatino
Paper:
Editorial:
Saying goodbye to Boston after an incredible
@ASCO
symposium
#ASCOQLTY23
Grateful for the knowledge and connections made
We even had time to enjoy Halloween, and Anne rocked her astronaut costume!
Until next time!
#ASCOQLTY24
I am going to frame this one!! Mentor and mentee
@IKCS2019
@KidneyCancer
Thank you
@montypal
I am honored to call you my mentor! You are incredible, and truly a great inspiration for me. Thanks for guiding me towards the right path
#BestMentorEver
Remarkable feasibility study on a remote physical activity program for pts w cancer undergoing IO
Over a 12-week period, pts experienced significant improvements in treatment-related side effects, fatigue, & overall QOL
@PauloBergerot
@ASCO
#ASCO23
♥️ Older pts (75+) who received single-agent anti–PD-1 immune checkpoint inhibitor therapy as standard of care had similar OS compared w younger patients (Abstract 12026)
#ASCO21
@ASCO
Discussant:
@melisawongmd